XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Millions
Total
Total Hippo Stockholders' Equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non controlling Interests
Beginning balance (in shares) at Dec. 31, 2021     22,601,245        
Beginning balance at Dec. 31, 2021 $ 861.7 $ 859.6 $ 0.0 $ 1,488.3 $ (0.7) $ (628.0) $ 2.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (66.5) (67.6)       (67.6) 1.1
Other comprehensive income (loss) (2.6) (2.6)     (2.6)    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     108,916        
Issuance of common stock from stock plans and contingently issuable shares 1.4 1.4   1.4      
Shares withheld related to net share settlement (1.0) (1.0)   (1.0)      
Stock-based compensation expense 15.7 15.7   15.7      
Ending balance (in shares) at Mar. 31, 2022     22,710,161        
Ending balance at Mar. 31, 2022 808.7 805.5 $ 0.0 1,504.4 (3.3) (695.6) 3.2
Beginning balance (in shares) at Dec. 31, 2021     22,601,245        
Beginning balance at Dec. 31, 2021 861.7 859.6 $ 0.0 1,488.3 (0.7) (628.0) 2.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (266.0)            
Ending balance (in shares) at Sep. 30, 2022     23,061,266        
Ending balance at Sep. 30, 2022 639.0 635.0 $ 0.0 1,540.8 (7.8) (898.0) 4.0
Beginning balance (in shares) at Mar. 31, 2022     22,710,161        
Beginning balance at Mar. 31, 2022 808.7 805.5 $ 0.0 1,504.4 (3.3) (695.6) 3.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (72.0) (73.5)       (73.5) 1.5
Other comprehensive income (loss) (1.6) (1.6)     (1.6)    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     187,934        
Issuance of common stock from stock plans and contingently issuable shares 2.3 2.3   2.3      
Repurchase of common stock (in shares)     (3,599)        
Shares withheld related to net share settlement (1.7) (1.7)   (1.7)      
Stock-based compensation expense 17.8 17.8   17.8      
Other (2.1) 0.3       0.3 (2.4)
Ending balance (in shares) at Jun. 30, 2022     22,894,496        
Ending balance at Jun. 30, 2022 751.4 749.1 $ 0.0 1,522.8 (4.9) (768.8) 2.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (127.5) (129.2)       (129.2) 1.7
Other comprehensive income (loss) (2.9) (2.9)     (2.9)    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     166,770        
Issuance of common stock from stock plans and contingently issuable shares 0.4 0.4   0.4      
Shares withheld related to net share settlement (0.8) (0.8)   (0.8)      
Stock-based compensation expense 18.4 18.4   18.4      
Ending balance (in shares) at Sep. 30, 2022     23,061,266        
Ending balance at Sep. 30, 2022 $ 639.0 635.0 $ 0.0 1,540.8 (7.8) (898.0) 4.0
Beginning balance (in shares) at Dec. 31, 2022 23,201,434   23,201,434        
Beginning balance at Dec. 31, 2022 $ 593.5 589.9 $ 0.0 1,558.0 (7.0) (961.1) 3.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (68.1) (69.8)       (69.8) 1.7
Other comprehensive income (loss) 1.7 1.7     1.7    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     134,824        
Issuance of common stock from stock plans and contingently issuable shares 0.4 0.4   0.4      
Repurchase of common stock (in shares)     (15,472)        
Repurchase of common stock (0.2) (0.2)   (0.2)      
Shares withheld related to net share settlement (0.9) (0.9)   (0.9)      
Stock-based compensation expense 17.4 17.4   17.4      
Other (0.8) (0.2)       (0.2) (0.6)
Ending balance (in shares) at Mar. 31, 2023     23,320,786        
Ending balance at Mar. 31, 2023 $ 543.0 538.3 $ 0.0 1,574.7 (5.3) (1,031.1) 4.7
Beginning balance (in shares) at Dec. 31, 2022 23,201,434   23,201,434        
Beginning balance at Dec. 31, 2022 $ 593.5 589.9 $ 0.0 1,558.0 (7.0) (961.1) 3.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss $ (223.7)            
Issuance of common stock from stock plans and contingently issuable shares (in shares) 103,002            
Repurchase of common stock (in shares) (100,000)            
Ending balance (in shares) at Sep. 30, 2023 23,891,930   23,891,930        
Ending balance at Sep. 30, 2023 $ 411.3 407.0 $ 0.0 1,606.1 (7.1) (1,192.0) 4.3
Beginning balance (in shares) at Mar. 31, 2023     23,320,786        
Beginning balance at Mar. 31, 2023 543.0 538.3 $ 0.0 1,574.7 (5.3) (1,031.1) 4.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (105.2) (107.8)       (107.8) 2.6
Other comprehensive income (loss) (1.1) (1.1)     (1.1)    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     375,844        
Issuance of common stock from stock plans and contingently issuable shares 1.8 1.8   1.8      
Repurchase of common stock (in shares)     (85,322)        
Repurchase of common stock (1.6) (1.6)   (1.6)      
Shares withheld related to net share settlement (2.0) (2.0)   (2.0)      
Stock-based compensation expense 18.0 18.0   18.0      
Other (5.9)           (5.9)
Ending balance (in shares) at Jun. 30, 2023     23,611,308        
Ending balance at Jun. 30, 2023 447.0 445.6 $ 0.0 1,590.9 (6.4) (1,138.9) 1.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (50.3) (53.1)       (53.1) 2.8
Other comprehensive income (loss) (0.7) (0.7)     (0.7)    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     280,622        
Issuance of common stock from stock plans and contingently issuable shares 0.6 0.6   0.6      
Shares withheld related to net share settlement (1.1) (1.1)   (1.1)      
Stock-based compensation expense 15.7 15.7   15.7      
Other $ 0.1           0.1
Ending balance (in shares) at Sep. 30, 2023 23,891,930   23,891,930        
Ending balance at Sep. 30, 2023 $ 411.3 $ 407.0 $ 0.0 $ 1,606.1 $ (7.1) $ (1,192.0) $ 4.3